PuSH - Publication Server of Helmholtz Zentrum München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Keenan, T.* ; Zhao, W.* ; Rasheed, A.* ; Ho, W.K.* ; Malik, R.* ; Felix, J.F.* ; Young, R.* ; Shah, N.* ; Samuel, M.A.* ; Sheikh, N.* ; Mucksavage, M.L.* ; Shah, O.* ; Li, J.* ; Morley, M.* ; Laser, A. ; Mallick, N.H.* ; Zaman, K.S.* ; Ishaq, M.* ; Rasheed, S.Z.* ; Memon, F.U.* ; Ahmed, F.* ; Hanif, B.* ; Lakhani, M.S.* ; Fahim, M.* ; Shardha, N.K.* ; Ahmed, N.* ; Mahmood, K.* ; Iqbal, W.* ; Akhtar, S.* ; Raheel, R.* ; O'Donnell, C.J.* ; Hengstenberg, C.* ; Marz, W.* ; Kathiresan, S.* ; Samani, N.* ; Goel, A.* ; Hopewell, J.C.* ; Chambers, J.* ; Cheng, Y.C.* ; Sharma, P.* ; Yang, Q.* ; Rosand, J.* ; Boncoraglio, G.B.* ; Kazmi, S.U.* ; Hakonarson, H.* ; Köttgen, A.* ; Kalogeropoulos, A.* ; Frossard, P.* ; Kamal, A.K.* ; Dichgans, M.* ; Cappola, T.P.* ; Reilly, M.P.* ; Danesh, J.* ; Rader, D.J.* ; Voight, B.F.* ; Saleheen, D.*

Causal assessment of serum urate levels in cardiometabolic diseases through a mendelian randomization study.

J. Am. Coll. Cardiol. 67, 407-416 (2016)
Publ. Version/Full Text DOI PMC
Closed
Open Access Green as soon as Postprint is submitted to ZB.
BACKGROUND: Although epidemiological studies have reported positive associations between circulating urate levels and cardiometabolic diseases, causality remains uncertain. OBJECTIVES: Through a Mendelian randomization approach, we assessed whether serum urate levels are causally relevant in type 2 diabetes mellitus (T2DM), coronary heart disease (CHD), ischemic stroke, and heart failure (HF). METHODS: This study investigated 28 single nucleotide polymorphisms known to regulate serum urate levels in association with various vascular and nonvascular risk factors to assess pleiotropy. To limit genetic confounding, 14 single nucleotide polymorphisms exclusively associated with serum urate levels were used in a genetic risk score to assess associations with the following cardiometabolic diseases (cases/controls): T2DM (26,488/83,964), CHD (54,501/68,275), ischemic stroke (14,779/67,312), and HF (4,526/18,400). As a positive control, this study also investigated our genetic instrument in 3,151 gout cases and 68,350 controls. RESULTS: Serum urate levels, increased by 1 SD due to the genetic score, were not associated with T2DM, CHD, ischemic stroke, or HF. These results were in contrast with previous prospective studies that did observe increased risks of these 4 cardiometabolic diseases for an equivalent increase in circulating urate levels. However, a 1 SD increase in serum urate levels due to the genetic score was associated with increased risk of gout (odds ratio: 5.84; 95% confidence interval: 4.56 to 7.49), which was directionally consistent with previous observations. CONCLUSIONS: Evidence from this study does not support a causal role of circulating serum urate levels in T2DM, CHD, ischemic stroke, or HF. Decreasing serum urate levels may not translate into risk reductions for cardiometabolic conditions.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
17.759
5.140
93
104
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Scientific Article
Keywords Genetic ; Pleiotropy ; Single Nucleotide Polymorphism
Language
Publication Year 2016
HGF-reported in Year 2016
ISSN (print) / ISBN 0735-1097
e-ISSN 1558-3597
Journal Journal of the American College of Cardiology
Quellenangaben Volume: 67, Issue: 4, Pages: 407-416 Article Number: , Supplement: ,
Publisher Elsevier
Publishing Place New York, NY
Reviewing status Peer reviewed
Institute(s) Institute of Epidemiology (EPI)
POF-Topic(s) 30202 - Environmental Health
Research field(s) Genetics and Epidemiology
PSP Element(s) G-504091-004
DOI 10.1016/j.jacc.2015.10.086
WOS ID WOS:000368615600009
Scopus ID 84959420157
PubMed ID 26821629
Erfassungsdatum 2016-01-31
[➜Report correction]